EGFR and lung adenocarcinoma: In this work, we first propose a radiogenomic workflow to characterize lung adenocarcinoma cases with respect to KRAS and EGFR mutational status using radiomic features extracted from the computed tomography (CT) images of patients affected by lung adenocarcinoma.